Continuous Saphenous Block Versus Continuous Femoral Block for Total Knee Arthroplasty

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by McGill University Health Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
McGill University Health Center
ClinicalTrials.gov Identifier:
NCT01250041
First received: November 26, 2010
Last updated: November 29, 2010
Last verified: November 2010

November 26, 2010
November 29, 2010
January 2011
August 2011   (final data collection date for primary outcome measure)
to assess the functional capacity and the impact of each block on the ability to walk by measuring the distance (the 2 minute walk test) in post op day one in the two groups. [ Time Frame: post op day one ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01250041 on ClinicalTrials.gov Archive Site
the morphine consumption in the two groups. [ Time Frame: post op day one ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Continuous Saphenous Block Versus Continuous Femoral Block for Total Knee Arthroplasty
Continuous Saphenous Block Vs. Continuous Femoral Block for Total Knee Arthroplasty: Prospective, Randomized, Double Blind Study.

Strength of the Quadriceps Muscle is key to recover from Total Knee Arthroplasty. In this study we compare two techniques for pain control after total knee arthroplasty in terms of preserving the motor function (the strength of the quadriceps muscles of the thigh) which will facilitate the rehabilitation and accelerate the hospital discharge. We will use ultrasound guided technique to block either the femoral nerve in the control group or the saphenous nerve in the experimental group. The primary outcome is the functional capacity and the impact of each block on the ability to walk by measuring the distance patients are able to walk in two minutes in post operative day one in the two groups. The secondary outcome is the morphine consumption in the two groups.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Outcomes Assessor)
Total Knee Arthroplasty Secondary to Osteoarthritis
  • Procedure: continuous femoral nerve block
    ultrasound guided femoral nerve catheter insertion.
  • Procedure: continuous saphenous nerve block
    ultrasound guided saphenous nerve catheter insertion
  • Active Comparator: femoral block
    Intervention: Procedure: continuous femoral nerve block
  • Experimental: saphenous block
    Intervention: Procedure: continuous saphenous nerve block
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
40
December 2011
August 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

- Subject age over 18 years coming for total knee arthroplasty secondary to osteoarthritis

Exclusion Criteria:

  • ASA 4-5
  • Abnormal liver enzymes, hepatic failure, renal failure and cardiac failure if they become contraindication for the use of regional anesthesia
  • Contraindications for spinal anesthesia
  • Morbid obesity
  • Organ transplant
  • Neuropathic pain
  • History of stroke or major neurological deficit
  • Sensory and motor disorders in the operated limb
  • Previous drug dependency
  • Chronic use of opioids
  • Allergy to local anesthetics
  • Inability to comprehend pain assessment
Both
18 Years and older
No
Contact: JF Asengo, MD (514) 934-1934 ext 43261 jfasenjog@yahoo.com
Canada
 
NCT01250041
10-153-SDR
No
JF Asenjo, MUHC
McGill University Health Center
Not Provided
Principal Investigator: JF Asenjo, MD McGill University Health Center
McGill University Health Center
November 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP